Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma.
Nakai Y, Takeuchi A, Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Minami K, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Morizane S, Kawasaki Y, Morooka D, Shimazui T, Yamamoto Y, Nakagomi H, Tomida R, Ito YM, Murai S, Kitamura H, Nishiyama H, Shinohara N; Japanese Urological Oncology Group.
Nakai Y, et al. Among authors: kawasaki y.
J Geriatr Oncol. 2021 Jun;12(5):834-837. doi: 10.1016/j.jgo.2020.12.012. Epub 2020 Dec 31.
J Geriatr Oncol. 2021.
PMID: 33388281
No abstract available.